These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33152936)

  • 1. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
    Guo S; Fu L; Wang B; Chen X; Zhao J; Liu M; Lu Y
    Biomed Pharmacother; 2020 Nov; 131():110777. PubMed ID: 33152936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
    Makarov V; Lechartier B; Zhang M; Neres J; van der Sar AM; Raadsen SA; Hartkoorn RC; Ryabova OB; Vocat A; Decosterd LA; Widmer N; Buclin T; Bitter W; Andries K; Pojer F; Dyson PJ; Cole ST
    EMBO Mol Med; 2014 Mar; 6(3):372-83. PubMed ID: 24500695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
    Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
    Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Ma C; Wang D; Wang A; Qin X; Liu M; Lu Y
    Eur J Med Chem; 2021 Jun; 218():113398. PubMed ID: 33823392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis.
    Lechartier B; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4457-63. PubMed ID: 25987624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Regimens Containing TBI-166, a New Drug Candidate against
    Zhang Y; Zhu H; Fu L; Wang B; Guo S; Chen X; Liu Z; Huang H; Yang T; Lu Y
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and antimycobacterial activity of new benzothiazinones inspired by rifampicin/rifapentine.
    Wang A; Lu Y; Lv K; Ma C; Xu S; Wang B; Wang A; Xia G; Liu M
    Bioorg Chem; 2020 Sep; 102():104135. PubMed ID: 32736151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones.
    Pasca MR; Degiacomi G; Ribeiro AL; Zara F; De Mori P; Heym B; Mirrione M; Brerra R; Pagani L; Pucillo L; Troupioti P; Makarov V; Cole ST; Riccardi G
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1616-8. PubMed ID: 20086151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the pharmacodynamic activity of combinations with the new anti-tuberculosis drug pyrifazimine
    Liu HT; Fu L; Wang B; Wang N; Li DS; Ding YM; Yao R; Qi XT; Lu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):560-566. PubMed ID: 35658380
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutations in
    Poulton NC; Azadian ZA; DeJesus MA; Rock JM
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0090422. PubMed ID: 35920665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
    Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
    Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
    Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
    Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
    Wang A; Ma C; Chai Y; Liu X; Lv K; Fu L; Wang B; Jia X; Liu M; Lu Y
    Eur J Med Chem; 2020 Aug; 200():112409. PubMed ID: 32460114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.